Home/Filings/4/0002092017-25-000005
4//SEC Filing

Patel Jeegar Pravinkumar 4

Accession 0002092017-25-000005

CIK 0002044725other

Filed

Nov 6, 7:00 PM ET

Accepted

Nov 7, 4:15 PM ET

Size

5.5 KB

Accession

0002092017-25-000005

Insider Transaction Report

Form 4
Period: 2025-11-05
Patel Jeegar Pravinkumar
Chief Scientific Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2025-11-05+179,619179,619 total
    Exercise: $16.00Exp: 2035-11-04Common Stock (179,619 underlying)
Footnotes (1)
  • [F1]One fourth (1/4) of the shares subject to the option award shall vest on November 5, 2026 and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Issuer

Evommune, Inc.

CIK 0002044725

Entity typeother

Related Parties

1
  • filerCIK 0002092017

Filing Metadata

Form type
4
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 4:15 PM ET
Size
5.5 KB